Xin Ming
Impact in
- Molecular Biology top 5%
- RNA Interference and Gene Delivery
- DNA and Nucleic Acid Chemistry
- Advanced biosensing and bioanalysis techniques
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 29
- Oncology 9
- Drug Transport and Resistance Mechanisms 7
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Rudy L. Juliano (22 shared papers)Osamu Nakagawa (7 shared papers)Kyle A. Carver (8 shared papers)Chengqiong Mao (14 shared papers)Brian M. Laing (4 shared papers)John A. Bauman (2 shared papers)Dhiren R. Thakker (5 shared papers)Hyun Min Kang (1 shared paper)
- Journals
- Molecular Pharmaceutics (6 papers)Nucleic Acids Research (4 papers)BioMed Research International (3 papers)Nucleic Acid Therapeutics (3 papers)Bioconjugate Chemistry (3 papers)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Xin Ming
63 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 91
- Molecular Biology 1.5k
- Biomaterials 288
- Oncology 253
- Biomedical Engineering 287
- Pharmaceutical Science 49
Countries citing papers authored by Xin Ming
This map shows the geographic impact of Xin Ming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Ming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Ming more than expected).
Fields of papers citing papers by Xin Ming
This network shows the impact of papers produced by Xin Ming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Ming. The network helps show where Xin Ming may publish in the future.
Co-authors
The 25 scholars most cited alongside Xin Ming, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 260 | |
| 2 | 2011 | 170 | |
| 3 | 2010 | 113 | |
| 4 | 2014 | 113 | |
| 5 | 2011 | 109 | |
| 6 | 2012 | 108 | |
| 7 | 2012 | 108 | |
| 8 | 2022 | 89 | |
| 9 | 2015 | 83 | |
| 10 | 2008 | 80 | |
| 11 | 2010 | 76 | |
| 12 | 2012 | 75 | |
| 13 | 2018 | 74 | |
| 14 | 2011 | 69 | |
| 15 | 2014 | 67 | |
| 16 | 2015 | 66 | |
| 17 | 2017 | 57 | |
| 18 | 2009 | 55 | |
| 19 | 2013 | 55 | |
| 20 | 2011 | 52 |
About Xin Ming
Xin Ming is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Hematology and Biomedical Engineering, having authored 63 papers that have together received 2.8k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (29 papers), Photodynamic Therapy Research Studies (9 papers), Nanoplatforms for cancer theranostics (7 papers), Drug Transport and Resistance Mechanisms (7 papers), Platelet Disorders and Treatments (5 papers), Virus-based gene therapy research (3 papers), Antimicrobial Peptides and Activities (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Molecular Biology (1.5k citations), Biomaterials (288 citations), Oncology (253 citations), Biomedical Engineering (287 citations) and Pharmaceutical Science (49 citations). Xin Ming has collaborated with scholars based in United States, China and Japan. Frequent co-authors include Rudy L. Juliano, Osamu Nakagawa, Kyle A. Carver, Chengqiong Mao, Brian M. Laing, John A. Bauman, Dhiren R. Thakker, Hyun Min Kang, Md. Rowshon Alam and Yi Kong. Their work appears in journals such as Molecular Pharmaceutics, Nucleic Acids Research, BioMed Research International, Nucleic Acid Therapeutics and Bioconjugate Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.